Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Ben-Josef

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Journal of the National Cancer Institute|March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapySteven H Lin, Thomas J George, Edgar Ben-Josef, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot studySteven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
The Oncologist|March 13, 2020
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704Marsha Reyngold, Kathryn A Winter, William F Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaTheodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 9, 2012
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN GuidelinesMargaret A Tempero, J Pablo Arnoletti, Stephen W Behrman, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Journal of the National Cancer Institute|March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapySteven H Lin, Thomas J George, Edgar Ben-Josef, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot studySteven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
The Oncologist|March 13, 2020
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704Marsha Reyngold, Kathryn A Winter, William F Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaTheodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 9, 2012
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN GuidelinesMargaret A Tempero, J Pablo Arnoletti, Stephen W Behrman, et al.
Pageof 13